Grupo de investigación

GC16 Biología celular en hematología. Hipercoagulabilidad

Información principal Equipo Proyectos Publicaciones Investigación clínica

Publicaciones 2023

Autores/as: Sargas C, Ayala R, Larrayoz MJ, Chillon MC, Rodriguez-Arboli E, Bilbao C, de la Torre EP, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua J, Algarra L, Tormo M, Martinez-Sanchez P, Soria E, Serrano J, Alonso-Dominguez JM, Garcia R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R, Perez-Simon JA, Casares MTG, Sanchez-Garcia J, Barragan E, Montesinos P

Título: Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group

Revista: BLOOD CANCER JOURNAL

DOI: 10.1038/s41408-023-00835-5

IF: 12,8

Sargas C, Ayala R, Larrayoz MJ, Chillon MC, Rodriguez-Arboli E, Bilbao C, de la Torre EP, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua J, Algarra L, Tormo M, Martinez-Sanchez P, Soria E, Serrano J, Alonso-Dominguez JM, Garcia R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R, Perez-Simon JA, Casares MTG, Sanchez-Garcia J, Barragan E, Montesinos P. Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. BLOOD CANCER JOURNAL. 2023. DOI: 10.1038/s41408-023-00835-5. IF: 12,8 Q1 D1

Autores/as: Aparicio-Perez C, de la Torre EP, Sanchez-Garcia J, Martin-Calvo C, Martinez-Losada C, Casano-Sanchez J, Serrano-Lopez J, Serrano J

Título: Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?

Revista: CANCERS

DOI: 10.3390/cancers15051425

IF: 5,2

Aparicio-Perez C, de la Torre EP, Sanchez-Garcia J, Martin-Calvo C, Martinez-Losada C, Casano-Sanchez J, Serrano-Lopez J, Serrano J. Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?. CANCERS. 2023. DOI: 10.3390/cancers15051425. IF: 5,2 Q2 D3

Autores/as: Sanchez-Garcia J, Serrano J, de La Torre EP, Serrano-Lopez J, Aparicio-Perez C, Barragan E, Montesinos P

Título: Identifying prognostic gene panels in acute myeloid leukemia

Revista: EXPERT REVIEW OF HEMATOLOGY

DOI: 10.1080/17474086.2023.2193322

IF: 2,8

Sanchez-Garcia J, Serrano J, de La Torre EP, Serrano-Lopez J, Aparicio-Perez C, Barragan E, Montesinos P. Identifying prognostic gene panels in acute myeloid leukemia. EXPERT REVIEW OF HEMATOLOGY. 2023. 277-287. DOI: 10.1080/17474086.2023.2193322. IF: 2,8 Q3 D

Autores/as: Sargas C, Ayala R, Larrayoz MJ, Chillon MC, Carrillo-Cruz E, Bilbao-Sieyro C, de la Torre EP, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua JM, Algarra L, Tormo M, Martinez-Sanchez P, Soria E, Serrano J, Alonso-Dominguez JM, Garcia-Boyero R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R, Perez-Simon JA, Gomez-Casares MT, Sanchez-Garcia J, Barragan E, Montesinos P

Título: Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry

Revista: CANCERS

DOI: 10.3390/cancers15020438

IF: 5,2

Sargas C, Ayala R, Larrayoz MJ, Chillon MC, Carrillo-Cruz E, Bilbao-Sieyro C, de la Torre EP, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua JM, Algarra L, Tormo M, Martinez-Sanchez P, Soria E, Serrano J, Alonso-Dominguez JM, Garcia-Boyero R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R, Perez-Simon JA, Gomez-Casares MT, Sanchez-Garcia J, Barragan E, Montesinos P. Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. CANCERS. 2023. DOI: 10.3390/cancers15020438. IF: 5,2 Q2 D3

Autores/as: Heredia G, Gonzalez-Manzanares R, Ojeda S, Molina JR, Fernandez-Aviles C, Hidalgo F, Lopez-Aguilera J, Crespin M, Mesa D, Anguita M, Castillo JC, Pan MN

Título: Right Ventricular Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia: From the CTOXALL Study

Revista: CANCERS

DOI: 10.3390/cancers15215158

IF: 5,2

Heredia G, Gonzalez-Manzanares R, Ojeda S, Molina JR, Fernandez-Aviles C, Hidalgo F, Lopez-Aguilera J, Crespin M, Mesa D, Anguita M, Castillo JC, Pan MN. Right Ventricular Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia: From the CTOXALL Study. CANCERS. 2023. DOI: 10.3390/cancers15215158. IF: 5,2 Q2 D3

Autores/as: Lopez-Pedrera C, Oteros R, Ibáñez-Costa A, Luque-Tévar M, Muñoz-Barrera L, Barbarroja N, Chicano-Gálvez E, Marta-Enguita J, Orbe J, Velasco F, Perez-Sanchez C

Título: The thrombus proteome in stroke reveals a key role of the innate immune system and new insights associated with its etiology, severity, and prognosis

Revista: JOURNAL OF THROMBOSIS AND HAEMOSTASIS

DOI: 10.1016/j.jtha.2023.04.015

IF: 10,4

Lopez-Pedrera C, Oteros R, Ibáñez-Costa A, Luque-Tévar M, Muñoz-Barrera L, Barbarroja N, Chicano-Gálvez E, Marta-Enguita J, Orbe J, Velasco F, Perez-Sanchez C. The thrombus proteome in stroke reveals a key role of the innate immune system and new insights associated with its etiology, severity, and prognosis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2023. 2894-2907. DOI: 10.1016/j.jtha.2023.04.015. IF: 10,4 Q1 D1

Autores/as: de la Rubia J, Alonso R, Clavero ME, Askari E, Garcia A, Anton C, Fernandez M, Escalante F, Garcia A, Rios-Tamayo R, Conesa V, Bermudez MA, Merchan B, Velasco AE, Blanchard MJ, Sampol A, Gainza E, Hernandez PM, Alegre A

Título: Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain

Revista: CANCERS

DOI: 10.3390/cancers15112964

IF: 5,2

de la Rubia J, Alonso R, Clavero ME, Askari E, Garcia A, Anton C, Fernandez M, Escalante F, Garcia A, Rios-Tamayo R, Conesa V, Bermudez MA, Merchan B, Velasco AE, Blanchard MJ, Sampol A, Gainza E, Hernandez PM, Alegre A. Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain. CANCERS. 2023. DOI: 10.3390/cancers15112964. IF: 5,2 Q2 D3

Autores/as: Montoro MJ, Pomares H, Coll R, del Castillo TB, Tormo M, Jimenez A, Brunet S, Casano J, Oiartzabal I, Diez-Campelo M, Ramos F, Romero R, Salido-Fierrez E, Pedro C, Bargay J, Munoz-Novas C, Lopez R, Rafel M, Valcarcel D

Título: Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice

Revista: LEUKEMIA & LYMPHOMA

DOI: 10.1080/10428194.2022.2154604

IF: 2,6

Montoro MJ, Pomares H, Coll R, del Castillo TB, Tormo M, Jimenez A, Brunet S, Casano J, Oiartzabal I, Diez-Campelo M, Ramos F, Romero R, Salido-Fierrez E, Pedro C, Bargay J, Munoz-Novas C, Lopez R, Rafel M, Valcarcel D. Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice. LEUKEMIA & LYMPHOMA. 2023. 679-690. DOI: 10.1080/10428194.2022.2154604. IF: 2,6 Q3 D

Autores/as: Moreno C, Ramos-Elbal E, Velasco P, Aguilar Y, Martinez BG, Fuentes C, Molinos A, Guerra-Garcia P, Palomo P, Verdu J, Pedroso RMA, Vagace JM, Lopez-Duarte M, Regueiro A, Tasso M, Dapena JL, Salinas JA, Navarro S, Bautista F, Lassaletta A, Lendinez F, Rives S, Pascual A, Rodriguez A, Perez-Hurtado JM, Fernandez JM, Perez-Martinez A, Gonzalez-Vicent M, de Heredia CD, Fuster JL

Título: Haploidentical vs

Revista: HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)

DOI: 10.3389/fped.2023.1140637

IF: 2,6

Moreno C, Ramos-Elbal E, Velasco P, Aguilar Y, Martinez BG, Fuentes C, Molinos A, Guerra-Garcia P, Palomo P, Verdu J, Pedroso RMA, Vagace JM, Lopez-Duarte M, Regueiro A, Tasso M, Dapena JL, Salinas JA, Navarro S, Bautista F, Lassaletta A, Lendinez F, Rives S, Pascual A, Rodriguez A, Perez-Hurtado JM, Fernandez JM, Perez-Martinez A, Gonzalez-Vicent M, de Heredia CD, Fuster JL. Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet). FRONTIERS IN PEDIATRICS. 2023. DOI: 10.3389/fped.2023.1140637. IF: 2,6 Q2 D4

Autores/as: Chumbita M, Puerta-Alcalde P, Yáñez L, Cuesta MA, Chinea A, Español-Morales I, Fernandez-Abellán P, Gudiol C, González-Sierra P, Rojas R, Sánchez-Pina JM, Vadillo IS, Sánchez M, Varela R, Vázquez L, Guerreiro M, Monzo P, Lopera C, Aiello TF, Peyrony O, Soriano A, Garcia-Vidal C

Título: High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations

Revista: MICROBIOLOGY SPECTRUM

DOI: 10.1128/spectrum.00674-23

IF: 3,7

Chumbita M, Puerta-Alcalde P, Yáñez L, Cuesta MA, Chinea A, Español-Morales I, Fernandez-Abellán P, Gudiol C, González-Sierra P, Rojas R, Sánchez-Pina JM, Vadillo IS, Sánchez M, Varela R, Vázquez L, Guerreiro M, Monzo P, Lopera C, Aiello TF, Peyrony O, Soriano A, Garcia-Vidal C. High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations. MICROBIOLOGY SPECTRUM. 2023. DOI: 10.1128/spectrum.00674-23. IF: 3,7 Q2 D5

Autores/as: García-Sancho AM, Rodríguez-Pinilla SM, Domingo-Domenech E, Climent F, Sánchez-Garcia J, Jiménez JL, Piqueras MGC, Castellvi J, González AJ, de Villambrosia SG, Codina JG, Navarro B, Rodríguez G, Borrero JJ, Fraga M, Naves A, Baeza L, Córdoba R

Título: Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study

Revista: BRITISH JOURNAL OF HAEMATOLOGY

DOI: 10.1111/bjh.18941

IF: 6,5

García-Sancho AM, Rodríguez-Pinilla SM, Domingo-Domenech E, Climent F, Sánchez-Garcia J, Jiménez JL, Piqueras MGC, Castellvi J, González AJ, de Villambrosia SG, Codina JG, Navarro B, Rodríguez G, Borrero JJ, Fraga M, Naves A, Baeza L, Córdoba R. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study. BRITISH JOURNAL OF HAEMATOLOGY. 2023. 182-193. DOI: 10.1111/bjh.18941. IF: 6,5 Q1 D3

Autores/as: Ramos F, Hermosín ML, Fuertes-Núñez M, Martínez P, Rodriguez-Medina C, Barrios M, Ibáñez F, Bernal T, Olave MT, Alvarez MA, Vahí M, Caballero-Velázquez T, González B, Altés A, García L, Fernández P, Durán MA, López R, Rafel M, Serrano J, Ranelletti FO

Título: Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice

Revista: JOURNAL OF PERSONALIZED MEDICINE

DOI: 10.3390/jpm13121667

IF: 3,4

Ramos F, Hermosín ML, Fuertes-Núñez M, Martínez P, Rodriguez-Medina C, Barrios M, Ibáñez F, Bernal T, Olave MT, Alvarez MA, Vahí M, Caballero-Velázquez T, González B, Altés A, García L, Fernández P, Durán MA, López R, Rafel M, Serrano J, Ranelletti FO. Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice. JOURNAL OF PERSONALIZED MEDICINE. 2023. DOI: 10.3390/jpm13121667. IF: 3,4 Q2 D4

Publicaciones 2022

Autores/as: Berard E, Rollig C, Bertoli S, Pigneux A, Tavitian S, Kramer M, Serve H, Bornhauser M, Platzbecker U, Muller-Tidow C, Baldus CD, Martinez-Cuadron D, Serrano J, Martinez-Sanchez P, Arboli ER, Gil C, Bergua J, Bernal T, Burguera AD, Delabesse E, Bidet A, Dumas PY, Montesinos P, Recher C

Título: BLOOD CANCER JOURNAL

Revista: 2022

DOI: 10.1038/s41408-022-00700-x

Berard E, Rollig C, Bertoli S, Pigneux A, Tavitian S, Kramer M, Serve H, Bornhauser M, Platzbecker U, Muller-Tidow C, Baldus CD, Martinez-Cuadron D, Serrano J, Martinez-Sanchez P, Arboli ER, Gil C, Bergua J, Bernal T, Burguera AD, Delabesse E, Bidet A, Dumas PY, Montesinos P, Recher C. BLOOD CANCER JOURNAL. 2022. DOI: 10.1038/s41408-022-00700-x

Autores/as: Hernandez-Boluda JC, Martinez-Cuadron D, Pereira A, Rodriguez-Veiga R, Boluda B, Gil C, Casal-Marini S, Serrano J, Martinez-Lopez J, Bergua J, Algarra L, Bernal T, Lopez-Lorenzo JL, Colorado M, Lopez A, Tormo M, Sayas MJ, Trigo F, Lopez-Pavia M, Perez-Simon JA, Lavilla-Rubira E, Rodriguez-Medina C, Rodriguez-Gutierrez JI, Sanz-Caballer MA, Montesinos P

Título: LEUKEMIA RESEARCH

Revista: 2022

DOI: 10.1016/j.leukres.2022.106821

Hernandez-Boluda JC, Martinez-Cuadron D, Pereira A, Rodriguez-Veiga R, Boluda B, Gil C, Casal-Marini S, Serrano J, Martinez-Lopez J, Bergua J, Algarra L, Bernal T, Lopez-Lorenzo JL, Colorado M, Lopez A, Tormo M, Sayas MJ, Trigo F, Lopez-Pavia M, Perez-Simon JA, Lavilla-Rubira E, Rodriguez-Medina C, Rodriguez-Gutierrez JI, Sanz-Caballer MA, Montesinos P. LEUKEMIA RESEARCH. 2022. DOI: 10.1016/j.leukres.2022.106821

Autores/as: Gutierrez A, Bento L, Novelli S, Martin A, Gutierrez G, Salas MQ, Bastos-Oreiro M, Perez A, Hernani R, Viguria MC, Lopez-Godino O, Montoro J, Pinana J, Ferra C, Parody R, Martin C, Espanol I, Yanez L, Rodriguez G, Zanabili J, Herrera P, Varela M, Sampol A, Solano C, Caballero D

Título: CANCERS

Revista: 2022

DOI: 10.3390/cancers14112673

Gutierrez A, Bento L, Novelli S, Martin A, Gutierrez G, Salas MQ, Bastos-Oreiro M, Perez A, Hernani R, Viguria MC, Lopez-Godino O, Montoro J, Pinana J, Ferra C, Parody R, Martin C, Espanol I, Yanez L, Rodriguez G, Zanabili J, Herrera P, Varela M, Sampol A, Solano C, Caballero D. CANCERS. 2022. DOI: 10.3390/cancers14112673

Autores/as: Gonzalez-Manzanares R, Castillo JC, Molina JR, Ruiz-Ortiz M, Mesa D, Ojeda S, Anguita M, Pan M

Título: CANCERS

Revista: 2022

DOI: 10.3390/cancers14061513

Gonzalez-Manzanares R, Castillo JC, Molina JR, Ruiz-Ortiz M, Mesa D, Ojeda S, Anguita M, Pan M. CANCERS. 2022. DOI: 10.3390/cancers14061513

Autores/as: Labrador J, Martinez-Cuadron D, de la Fuente A, Rodriguez-Veiga R, Serrano J, Tormo M, Rodriguez-Arboli E, Ramos F, Bernal T, Lopez-Pavia M, Trigo F, Martinez-Sanchez MP, Rodriguez-Gutierrez JI, Rodriguez-Medina C, Gil C, Belmonte DG, Vives S, Foncillas MA, Perez-Encinas M, Novo A, Recio I, Rodriguez-Macias G, Bergua JM, Noriega V, Lavilla E, Roldan-Perez A, Sanz MA, Montesinos P

Título: CANCERS

Revista: 2022

DOI: 10.3390/cancers14092342

Labrador J, Martinez-Cuadron D, de la Fuente A, Rodriguez-Veiga R, Serrano J, Tormo M, Rodriguez-Arboli E, Ramos F, Bernal T, Lopez-Pavia M, Trigo F, Martinez-Sanchez MP, Rodriguez-Gutierrez JI, Rodriguez-Medina C, Gil C, Belmonte DG, Vives S, Foncillas MA, Perez-Encinas M, Novo A, Recio I, Rodriguez-Macias G, Bergua JM, Noriega V, Lavilla E, Roldan-Perez A, Sanz MA, Montesinos P. CANCERS. 2022. DOI: 10.3390/cancers14092342

Autores/as: Martinez-Cuadron D, Serrano J, Mariz J, Gil C, Tormo M, Martinez-Sanchez P, Rodriguez-Arboli E, Garcia-Boyero R, Rodriguez-Medina C, Martinez-Chamorro C, Polo M, Bergua J, Aguiar E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Espadana A, Sayas MJ, Algarra L, Vidriales MB, Vasconcelos G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Chillon MC, Rodriguez-Gutierrez JI, Calasanz MJ, Labrador J, Lopez JA, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Barragan E, Sanz MA, Montesinos P

Título: CANCERS

Revista: 2022

DOI: 10.3390/cancers14112817

Martinez-Cuadron D, Serrano J, Mariz J, Gil C, Tormo M, Martinez-Sanchez P, Rodriguez-Arboli E, Garcia-Boyero R, Rodriguez-Medina C, Martinez-Chamorro C, Polo M, Bergua J, Aguiar E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Espadana A, Sayas MJ, Algarra L, Vidriales MB, Vasconcelos G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Chillon MC, Rodriguez-Gutierrez JI, Calasanz MJ, Labrador J, Lopez JA, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Barragan E, Sanz MA, Montesinos P. CANCERS. 2022. DOI: 10.3390/cancers14112817

Autores/as: Albasanz-Puig A, Dura-Miralles X, Laporte-Amargos J, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo JM, Mikulska M, Martin-Davila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, Garcia E, Isler B, Kern WV, Retamar-Gentil P, Aguado JM, Montero M, Kanj SS, Sipahi OR, Calik S, Marquez-Gomez I, Marin JI, Gomes MZR, Hemmati P, Araos R, Peghin M, del Pozo JL, Yanez L, Tilley R, Manzur A, Novo A, Pallares N, Bergas A, Carratala J, Gudiol C

Título: MICROORGANISMS

Revista: 2022

DOI: 10.3390/microorganisms10040733

Albasanz-Puig A, Dura-Miralles X, Laporte-Amargos J, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo JM, Mikulska M, Martin-Davila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, Garcia E, Isler B, Kern WV, Retamar-Gentil P, Aguado JM, Montero M, Kanj SS, Sipahi OR, Calik S, Marquez-Gomez I, Marin JI, Gomes MZR, Hemmati P, Araos R, Peghin M, del Pozo JL, Yanez L, Tilley R, Manzur A, Novo A, Pallares N, Bergas A, Carratala J, Gudiol C. MICROORGANISMS. 2022. DOI: 10.3390/microorganisms10040733

Autores/as: Gomez VG, Regano LD, Villa AR, Rubio CD, Vicent MG, Serra IB, Fernandez JM, Martinez AIP, Hurtado JMP, Duarte ML, Regalado MSM, Perez-Martinez A

Título: ANALES DE PEDIATRIA

Revista: 2022

DOI: 10.1016/j.anpedi.2021.02.015

Gomez VG, Regano LD, Villa AR, Rubio CD, Vicent MG, Serra IB, Fernandez JM, Martinez AIP, Hurtado JMP, Duarte ML, Regalado MSM, Perez-Martinez A. ANALES DE PEDIATRIA. 2022. DOI: 10.1016/j.anpedi.2021.02.015

Autores/as: Lopez JS, Jimenez-Jimenez C, Chutipongtanate S, Serrano J, Rodriguez-Moreno M, Jimenez A, Jimenez Y, Pedrero SG, Lainez D, Alonso-Dominguez JM, Sillero PL, Piris MA, Sanchez-Garcia J

Título: LEUKEMIA & LYMPHOMA

Revista: 2022

DOI: 10.1080/10428194.2022.2056173

Lopez JS, Jimenez-Jimenez C, Chutipongtanate S, Serrano J, Rodriguez-Moreno M, Jimenez A, Jimenez Y, Pedrero SG, Lainez D, Alonso-Dominguez JM, Sillero PL, Piris MA, Sanchez-Garcia J. LEUKEMIA & LYMPHOMA. 2022. DOI: 10.1080/10428194.2022.2056173

Autores/as: Sancho JM, Marin-Niebla A, Fernandez S, Capote FJ, Canigral C, Grande C, Donato E, Zeberio I, Puerta JM, Rivas A, Perez-Ceballos E, Vale A, Garcia-Sancho AM, Salar A, Gonzalez-Barca E, Teruel A, Pastoriza C, Conde-Royo D, Sanchez-Garcia J, Barrenetxea C, Arranz R, Hernandez-Rivas JA, Ramirez MJ, Jimenez A, Rubio-Azpeitia E

Título: INTERNATIONAL JOURNAL OF HEMATOLOGY

Revista: 2022

DOI: 10.1007/s12185-022-03367-z

Sancho JM, Marin-Niebla A, Fernandez S, Capote FJ, Canigral C, Grande C, Donato E, Zeberio I, Puerta JM, Rivas A, Perez-Ceballos E, Vale A, Garcia-Sancho AM, Salar A, Gonzalez-Barca E, Teruel A, Pastoriza C, Conde-Royo D, Sanchez-Garcia J, Barrenetxea C, Arranz R, Hernandez-Rivas JA, Ramirez MJ, Jimenez A, Rubio-Azpeitia E. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2022. DOI: 10.1007/s12185-022-03367-z

Autores/as: Ayala R, Carreno-Tarragona G, Barragan E, Boluda B, Larrayoz MJ, Chillon MC, Carrillo-Cruz E, Bilbao C, Sanchez-Garcia J, Bernal T, Martinez-Cuadron D, Gil C, Serrano J, Rodriguez-Medina C, Bergua J, Perez-Simon JA, Calbacho M, Alonso-Dominguez JM, Labrador J, Tormo M, Amigo ML, Herrera-Puente P, Rapado I, Sargas C, Vazquez I, Calasanz MJ, Gomez-Casares T, Garcia-Sanz R, Sanz MA, Martinez-Lopez J, Montesinos P

Título: CANCERS

Revista: 2022

DOI: 10.3390/cancers14235799

Ayala R, Carreno-Tarragona G, Barragan E, Boluda B, Larrayoz MJ, Chillon MC, Carrillo-Cruz E, Bilbao C, Sanchez-Garcia J, Bernal T, Martinez-Cuadron D, Gil C, Serrano J, Rodriguez-Medina C, Bergua J, Perez-Simon JA, Calbacho M, Alonso-Dominguez JM, Labrador J, Tormo M, Amigo ML, Herrera-Puente P, Rapado I, Sargas C, Vazquez I, Calasanz MJ, Gomez-Casares T, Garcia-Sanz R, Sanz MA, Martinez-Lopez J, Montesinos P. CANCERS. 2022. DOI: 10.3390/cancers14235799

Autores/as: Recher C, Rollig C, Berard E, Bertoli S, Dumas PY, Tavitian S, Kramer M, Serve H, Bornhauser M, Platzbecker U, Muller-Tidow C, Baldus CD, Martinez-Cuadron D, Serrano J, Martinez-Sanchez P, Arboli ER, Gil C, Bergua J, Bernal T, Burguera AD, Delabesse E, Bidet A, Pigneux A, Montesinos P

Título: LEUKEMIA

Revista: 2022

DOI: 10.1038/s41375-021-01425-9

Recher C, Rollig C, Berard E, Bertoli S, Dumas PY, Tavitian S, Kramer M, Serve H, Bornhauser M, Platzbecker U, Muller-Tidow C, Baldus CD, Martinez-Cuadron D, Serrano J, Martinez-Sanchez P, Arboli ER, Gil C, Bergua J, Bernal T, Burguera AD, Delabesse E, Bidet A, Pigneux A, Montesinos P. LEUKEMIA. 2022. DOI: 10.1038/s41375-021-01425-9

Autores/as: Macias-Sanchez MD, Morata-Tarifa C, Cuende N, Cardesa-Gil A, Cuesta-Casas MA, Pascual-Cascon MJ, Pascual A, Martin-Calvo C, Jurado M, Perez-Simon JA, Espigado I, Lopez SG, Sanchez GC, Mata-Alcazar-Caballero R, Sanchez-Pernaute R

Título: STEM CELLS TRANSLATIONAL MEDICINE

Revista: 2022

DOI: 10.1093/stcltm/szac003

Macias-Sanchez MD, Morata-Tarifa C, Cuende N, Cardesa-Gil A, Cuesta-Casas MA, Pascual-Cascon MJ, Pascual A, Martin-Calvo C, Jurado M, Perez-Simon JA, Espigado I, Lopez SG, Sanchez GC, Mata-Alcazar-Caballero R, Sanchez-Pernaute R. STEM CELLS TRANSLATIONAL MEDICINE. 2022. DOI: 10.1093/stcltm/szac003

Autores/as: Castano-Bonilla T, Barragan E, Sargas C, Sanz A, Algarra L, Herrera-Puente P, Garcia-Boyero R, Barrios M, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Serrano-Lopez J, Martinez-Lopez J, Sayas-Lloris MJ, Olave MT, Riaza-Grau R, Bernal-Del Castillo T, Larrayoz MJ, Amigo R, Jimenez-Velasco A, Sanchez J, Ayala R, Blas C, Lainez D, Serrano-Lopez J, Sanz MA, Alonso-Dominguez JM, Montesinos P

Título: DISEASE MARKERS

Revista: 2022

DOI: 10.1155/2022/3132941

Castano-Bonilla T, Barragan E, Sargas C, Sanz A, Algarra L, Herrera-Puente P, Garcia-Boyero R, Barrios M, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Serrano-Lopez J, Martinez-Lopez J, Sayas-Lloris MJ, Olave MT, Riaza-Grau R, Bernal-Del Castillo T, Larrayoz MJ, Amigo R, Jimenez-Velasco A, Sanchez J, Ayala R, Blas C, Lainez D, Serrano-Lopez J, Sanz MA, Alonso-Dominguez JM, Montesinos P. DISEASE MARKERS. 2022. DOI: 10.1155/2022/3132941

Autores/as: Vilorio-Marques L, Fernandez CC, Mora E, Gutierrez L, Bua BR, Lorenzo MJJ, Beya MD, Pampliega MV, Molero A, Sanchez-Garcia J, Calabuig M, Cedena MT, Chen-Liang T, Santa JAD, Padilla I, Hernandez F, Diez R, Asensi P, Xicoy B, Sanz G, Valcarcel D, Diez-Campelo M, Bernal T

Título: THERAPEUTIC ADVANCES IN HEMATOLOGY

Revista: 2022

DOI: 10.1177/20406207221127547

Vilorio-Marques L, Fernandez CC, Mora E, Gutierrez L, Bua BR, Lorenzo MJJ, Beya MD, Pampliega MV, Molero A, Sanchez-Garcia J, Calabuig M, Cedena MT, Chen-Liang T, Santa JAD, Padilla I, Hernandez F, Diez R, Asensi P, Xicoy B, Sanz G, Valcarcel D, Diez-Campelo M, Bernal T. THERAPEUTIC ADVANCES IN HEMATOLOGY. 2022. DOI: 10.1177/20406207221127547

Autores/as: Chumbita M, Puerta-Alcalde P, Yanez L, Cuesta MA, Chinea A, Morales IE, Abellan PF, Gudiol C, Guerreiro M, Gonzalez-Sierra P, Rojas R, Pina JMS, Vadillo IS, Varela R, Vazquez L, Lopera C, Monzo P, Garcia-Vidal C

Título: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Revista: 2022

DOI: 10.1093/jac/dkac135

Chumbita M, Puerta-Alcalde P, Yanez L, Cuesta MA, Chinea A, Morales IE, Abellan PF, Gudiol C, Guerreiro M, Gonzalez-Sierra P, Rojas R, Pina JMS, Vadillo IS, Varela R, Vazquez L, Lopera C, Monzo P, Garcia-Vidal C. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022. DOI: 10.1093/jac/dkac135

Autores/as: Villar S, Ariceta B, Agirre X, Urribarri AD, Ayala R, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Simoes C, Herrera P, Calasanz MJ, Alfonso-Pierola A, Paiva B, Martinez-Lopez J, San Miguel JF, Prosper F, Montesinos P

Título: FRONTIERS IN ONCOLOGY

Revista: 2022

DOI: 10.3389/fonc.2022.1054458

Villar S, Ariceta B, Agirre X, Urribarri AD, Ayala R, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Simoes C, Herrera P, Calasanz MJ, Alfonso-Pierola A, Paiva B, Martinez-Lopez J, San Miguel JF, Prosper F, Montesinos P. FRONTIERS IN ONCOLOGY. 2022. DOI: 10.3389/fonc.2022.1054458

Autores/as: Martinez-Cuadron D, Megias-Vericat JE, Serrano J, Martinez-Sanchez P, Rodriguez-Arboli E, Gil C, Aguiar E, Bergua J, Lopez-Lorenzo JL, Bernal T, Espadana A, Colorado M, Rodriguez-Medina C, Lopez-Pavia M, Tormo M, Algarra L, Amigo ML, Sayas MJ, Labrador J, Rodriguez-Gutierrez JI, Benavente C, Costilla-Barriga L, Garcia-Boyero R, Lavilla-Rubira E, Vives S, Herrera P, Garcia-Belmonte D, Herraez MM, Esteves GV, Gomez-Roncero MI, Cabello A, Bautista G, Balerdi A, Mariz J, Boluda B, Sanz MA, Montesinos P

Título: BLOOD ADVANCES

Revista: 2022

DOI: 10.1182/bloodadvances.2021005335

Martinez-Cuadron D, Megias-Vericat JE, Serrano J, Martinez-Sanchez P, Rodriguez-Arboli E, Gil C, Aguiar E, Bergua J, Lopez-Lorenzo JL, Bernal T, Espadana A, Colorado M, Rodriguez-Medina C, Lopez-Pavia M, Tormo M, Algarra L, Amigo ML, Sayas MJ, Labrador J, Rodriguez-Gutierrez JI, Benavente C, Costilla-Barriga L, Garcia-Boyero R, Lavilla-Rubira E, Vives S, Herrera P, Garcia-Belmonte D, Herraez MM, Esteves GV, Gomez-Roncero MI, Cabello A, Bautista G, Balerdi A, Mariz J, Boluda B, Sanz MA, Montesinos P. BLOOD ADVANCES. 2022. DOI: 10.1182/bloodadvances.2021005335

Autores/as: Ruiz-Llobet A, Gassiot S, Sarrate E, Zubicaray J, Dapena JL, Rives S, Sevilla J, Lopez AM, Romero MP, Montoya C, Vagace JM, Hurtado JRM, Garcia-Morin M, Abos MG, Sanchez MCM, Lendinez F, Moraleda PP, Tallon M, Gonzalez B, Urrutia E, Serna JV, Pleguezuelos IP, Merino MM, Elbal ER, Orellana E, Munoz HB, Berrueco R

Título: JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Revista: 2022

DOI: 10.1111/jth.15699

Ruiz-Llobet A, Gassiot S, Sarrate E, Zubicaray J, Dapena JL, Rives S, Sevilla J, Lopez AM, Romero MP, Montoya C, Vagace JM, Hurtado JRM, Garcia-Morin M, Abos MG, Sanchez MCM, Lendinez F, Moraleda PP, Tallon M, Gonzalez B, Urrutia E, Serna JV, Pleguezuelos IP, Merino MM, Elbal ER, Orellana E, Munoz HB, Berrueco R. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2022. DOI: 10.1111/jth.15699

Publicaciones 2021

Autores/as: Perez-Sanchez L, Patino-Trives AM, Aguirre-Zamorano MA, Luque-Tevar M, Abalos-Aguilera MC, Arias-de La Rosa I, Segui P, Velasco-Gimena F, Barbarroja N, Escudero-Contreras A, Collantes-Estevez E, Perez-Sanchez C, Lopez-Pedrera C

Título: Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses

Revista: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

DOI: 10.1161/ATVBAHA.120.315346

Perez-Sanchez L, Patino-Trives AM, Aguirre-Zamorano MA, Luque-Tevar M, Abalos-Aguilera MC, Arias-de La Rosa I, Segui P, Velasco-Gimena F, Barbarroja N, Escudero-Contreras A, Collantes-Estevez E, Perez-Sanchez C, Lopez-Pedrera C. Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 202 41(2):865-877. DOI: 10.1161/ATVBAHA.120.315346.

Autores/as: IF: 8,311 Q1 D1

IF: 8,311

IF: 8,311 Q1 D1

Autores/as: Vives S, Martinez-Cuadron D, Burgues JB, Algarra L, Tormo M, Martinez-Sanchez MP, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Lopez-Lorenzo JL, Gil C, Vidriales B, Falantes JF, Serrano A, Labrador J, Sayas MJ, Foncillas MA, Barciela MLA, Olave MT, Colorado M, Gascon A, Fernandez MA, Simiele A, Perez-Encinas MM, Rodriguez-Veiga R, Garcia O, Martinez-Lopez J, Barragan E, Paiva B, Sanz MA, Montesinos P

Título: A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia

Revista: CANCER

DOI: 10.1002/cncr.33403

Vives S, Martinez-Cuadron D, Burgues JB, Algarra L, Tormo M, Martinez-Sanchez MP, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Lopez-Lorenzo JL, Gil C, Vidriales B, Falantes JF, Serrano A, Labrador J, Sayas MJ, Foncillas MA, Barciela MLA, Olave MT, Colorado M, Gascon A, Fernandez MA, Simiele A, Perez-Encinas MM, Rodriguez-Veiga R, Garcia O, Martinez-Lopez J, Barragan E, Paiva B, Sanz MA, Montesinos P. A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia. CANCER. 2021. 127(12):2003-2014. DOI: 10.1002/cncr.33403.

Autores/as: IF: 6,86 Q1 D2

IF: 6,86

IF: 6,86 Q1 D2

Autores/as: Bento L, Gutierrez A, Novelli S, Montoro J, Pinana JL, Lopez-Corral L, Cabrero M, Martin-Sancho A, Gutierrez-Garcia G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Perez A, Hernani R, Ferra C, Parody R, Garcia-Cadenas I, Herrera P, Rodriguez G, Rodriguez N, Martin C, Yanez L, Zanabili J, Varela MR, Lopez-Godino O, Heras I, Espanol I, Martinez C, Perez-Simon JA, Solano C, Sureda A, Sierra J, Sampol A, Caballero D

Título: Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

Revista: BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-021-01264-

Bento L, Gutierrez A, Novelli S, Montoro J, Pinana JL, Lopez-Corral L, Cabrero M, Martin-Sancho A, Gutierrez-Garcia G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Perez A, Hernani R, Ferra C, Parody R, Garcia-Cadenas I, Herrera P, Rodriguez G, Rodriguez N, Martin C, Yanez L, Zanabili J, Varela MR, Lopez-Godino O, Heras I, Espanol I, Martinez C, Perez-Simon JA, Solano C, Sureda A, Sierra J, Sampol A, Caballero D. Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study. BONE MARROW TRANSPLANTATION. 2021. 56(8):1919-1928. DOI: 10.1038/s41409-021-01264-

Autores/as: IF: 5,483 Q1 D3

IF: 5,483

IF: 5,483 Q1 D3

Autores/as: Palanques-Pastor T, Megias-Vericat JE, Martinez P, Lorenzo JLL, Navascues JC, Macias GR, Cano I, Sangerman MA, Vicente MBV, Algarra JLA, Foncillas MA, Herrera P, Prieto CB, Vives S, Alvarez AF, Palomares LC, Sobas M, Gonzalo AC, Garcia RC, Diez MEA, Llorente DD, Elorza BN, Burgues JMB, Del Castillo TB, Rodriguez MCM, Lopez ED, Villegas ACF, Boyero RG, Escobar CE, Merino CS, Cervero C, Perez AR, Ramos LH, Calvo MC, Olave MT, Gutierrez PV, de Laiglesiai A, Serrano J, Irazu MJN, Pinana JL, Sanz MA, Martinez-Lopez J, Montesinos P

Título: Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group

Revista: LEUKEMIA & LYMPHOMA

DOI: 10.1080/10428192021.1948031

Palanques-Pastor T, Megias-Vericat JE, Martinez P, Lorenzo JLL, Navascues JC, Macias GR, Cano I, Sangerman MA, Vicente MBV, Algarra JLA, Foncillas MA, Herrera P, Prieto CB, Vives S, Alvarez AF, Palomares LC, Sobas M, Gonzalo AC, Garcia RC, Diez MEA, Llorente DD, Elorza BN, Burgues JMB, Del Castillo TB, Rodriguez MCM, Lopez ED, Villegas ACF, Boyero RG, Escobar CE, Merino CS, Cervero C, Perez AR, Ramos LH, Calvo MC, Olave MT, Gutierrez PV, de Laiglesiai A, Serrano J, Irazu MJN, Pinana JL, Sanz MA, Martinez-Lopez J, Montesinos P. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group. LEUKEMIA & LYMPHOMA. 2021. 62(12):2928-2938. DOI: 10.1080/10428192021.1948031.

Autores/as: IF: 3,28 Q3

IF: 3,28

IF: 3,28 Q3

Autores/as: Ribera JM, Morgades M, Ciudad J, Montesinos P, Esteve J, Genesca E, Barba P, Ribera J, Garcia-Cadenas I, Moreno MJ, Martinez-Carballeira D, Torrent A, Martinez-Sanchez P, Monsalvo S, Gil C, Tormo M, Artola MT, Cervera M, Gonzalez-Campos J, Rodriguez C, Bermudez A, Novo A, Soria B, Coll R, Amigo ML, Lopez-Martinez A, Fernandez-Martin R, Serrano J, Mercadal S, Cladera A, Gimenez-Conca A, Penarrubia MJ, Abella E, Vall-llovera F, Hernandez-Rivas JM, Garcia-Guinon A, Bergua JM, de Rueda B, Sanchez-Sanchez MJ, Serrano A, Calbacho M, Alonso N, Mendez-Sanchez JA, Garcia-Boyero R, Olivares M, Barrena S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A

Título: Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia

Revista: BLOOD

DOI: 10.1182/blood.2020007311

Ribera JM, Morgades M, Ciudad J, Montesinos P, Esteve J, Genesca E, Barba P, Ribera J, Garcia-Cadenas I, Moreno MJ, Martinez-Carballeira D, Torrent A, Martinez-Sanchez P, Monsalvo S, Gil C, Tormo M, Artola MT, Cervera M, Gonzalez-Campos J, Rodriguez C, Bermudez A, Novo A, Soria B, Coll R, Amigo ML, Lopez-Martinez A, Fernandez-Martin R, Serrano J, Mercadal S, Cladera A, Gimenez-Conca A, Penarrubia MJ, Abella E, Vall-llovera F, Hernandez-Rivas JM, Garcia-Guinon A, Bergua JM, de Rueda B, Sanchez-Sanchez MJ, Serrano A, Calbacho M, Alonso N, Mendez-Sanchez JA, Garcia-Boyero R, Olivares M, Barrena S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia. BLOOD. 2021. 137(14):1879-1894. DOI: 10.1182/blood.2020007311.

Autores/as: IF: 22,113 Q1 D1

IF: 22,113

IF: 22,113 Q1 D1

Autores/as: Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Seoane CP, Jimenez JL, Garcia-Cosio M, Caballero D, Munez OJB, Carpio C, Castellvi J, Pozo AM, Farre BG, Bendana A, Aliste C, Gonzalez AJ, de Villambrosia SG, Piris MA, Codina JG, Mayordomo-Aranda E, Navarro B, Bellas C, Rodriguez G, Borrero JJ, Ruiz-Zorrilla A, Grande M, Montoto C, Cordoba R

Título: Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study

Revista: BRITISH JOURNAL OF HAEMATOLOGY

DOI: 10.1111/bjh.16741

Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Seoane CP, Jimenez JL, Garcia-Cosio M, Caballero D, Munez OJB, Carpio C, Castellvi J, Pozo AM, Farre BG, Bendana A, Aliste C, Gonzalez AJ, de Villambrosia SG, Piris MA, Codina JG, Mayordomo-Aranda E, Navarro B, Bellas C, Rodriguez G, Borrero JJ, Ruiz-Zorrilla A, Grande M, Montoto C, Cordoba R. Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study. BRITISH JOURNAL OF HAEMATOLOGY. 2021. 192(1):82-99. DOI: 10.1111/bjh.16741.

Autores/as: IF: 6,998 Q1 D2

IF: 6,998

IF: 6,998 Q1 D2

Autores/as: Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo CM, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta AJ, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta MA, Pinana JL, Navarro D

Título: Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment

Revista: BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-020-01157-x

Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo CM, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta AJ, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta MA, Pinana JL, Navarro D. Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment. BONE MARROW TRANSPLANTATION. 2021. 56(6):1281-1290. DOI: 10.1038/s41409-020-01157-x.

Autores/as: IF: 5,483 Q1 D3

IF: 5,483

IF: 5,483 Q1 D3

Autores/as: Janusz K, Izquierdo MM, Cadenas FL, Ramos F, Sanchez JMH, Lumbreras E, Robledo C, del Real JS, Caballero JC, Collado R, Bernal T, Pedro C, Insunza A, de Paz R, Xicoy B, Salido E, Garcia JS, Minguez SS, Garcia CM, Munoz AMS, Barba MS, Rivas JMH, Abaigar M, Campelo MD

Título: Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients

Revista: ANNALS OF HEMATOLOGY

DOI: 10.1007/s00277-020-04360-4

Janusz K, Izquierdo MM, Cadenas FL, Ramos F, Sanchez JMH, Lumbreras E, Robledo C, del Real JS, Caballero JC, Collado R, Bernal T, Pedro C, Insunza A, de Paz R, Xicoy B, Salido E, Garcia JS, Minguez SS, Garcia CM, Munoz AMS, Barba MS, Rivas JMH, Abaigar M, Campelo MD. Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients. ANNALS OF HEMATOLOGY. 2021. 100(8):1995-2004. DOI: 10.1007/s00277-020-04360-4.

Autores/as: IF: 3,673 Q2 D5

IF: 3,673

IF: 3,673 Q2 D5

Autores/as: Rodriguez DC, Urain TA, Rodriguez AC, Torres EG, Vicent MG, Garcia GG, Garcia AR, Hidalgo MC, Villacampa A

Título: Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain

Revista: JOURNAL OF MEDICAL ECONOMICS

DOI: 10.1080/13696998.2021.191674

Rodriguez DC, Urain TA, Rodriguez AC, Torres EG, Vicent MG, Garcia GG, Garcia AR, Hidalgo MC, Villacampa A. Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain. JOURNAL OF MEDICAL ECONOMICS. 2021. 24(1):628-636. DOI: 10.1080/13696998.2021.191674

Autores/as: IF: 2,448 Q2 D5

IF: 2,448

IF: 2,448 Q2 D5

Autores/as: Vicent MG, de Heredia CD, de Pablo JG, Molina B, Regueiro A, Martinez AP, Palomo P, Corral LL, Garcia E, Fernandez JM, Perez A, Jimenez MJ, Guerreiro M, Vallejo C, Gallardo AI, Lopez O, Benito A, Marsal J, Duarte M, Bento L, Badell I, Pedraza A, Ubieto AJ, Gonzalez P, Centurion IG, Costilla L, Belendez C, Esquirol A, Espigado I, Lavilla E, Diaz MA

Título: Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)

Revista: EUROPEAN JOURNAL OF HAEMATOLOGY

DOI: 1111/ejh.13618

IF: 2,997

Vicent MG, de Heredia CD, de Pablo JG, Molina B, Regueiro A, Martinez AP, Palomo P, Corral LL, Garcia E, Fernandez JM, Perez A, Jimenez MJ, Guerreiro M, Vallejo C, Gallardo AI, Lopez O, Benito A, Marsal J, Duarte M, Bento L, Badell I, Pedraza A, Ubieto AJ, Gonzalez P, Centurion IG, Costilla L, Belendez C, Esquirol A, Espigado I, Lavilla E, Diaz MA. Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH). EUROPEAN JOURNAL OF HAEMATOLOGY. 2021. 106(6):842-850. DOI: 1111/ejh.13618. IF: 2,997 Q3

Autores/as: Martinez-Cuadron D, Serrano J, Gil C, Tormo M, Martinez-Sanchez P, Perez-Simon JA, Garcia-Boyero R, Rodriguez-Medina C, Lopez-Pavia M, Benavente C, Bergua J, Lavilla-Rubira E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Colorado M, Sayas MJ, Algarra L, Vidriales MB, Rodriguez-Macias G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Ramos F, Rodriguez-Gutierrez JI, Costilla-Barriga L, Labrador J, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Sanz MA, Montesinos P

Título: Evolving treatment patterns and outcomes in older patients (>= 60 years) with AML: changing everything to change nothing?

Revista: LEUKEMIA

DOI: 10.1038/s41375-020-01058-4

Martinez-Cuadron D, Serrano J, Gil C, Tormo M, Martinez-Sanchez P, Perez-Simon JA, Garcia-Boyero R, Rodriguez-Medina C, Lopez-Pavia M, Benavente C, Bergua J, Lavilla-Rubira E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Colorado M, Sayas MJ, Algarra L, Vidriales MB, Rodriguez-Macias G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Ramos F, Rodriguez-Gutierrez JI, Costilla-Barriga L, Labrador J, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Sanz MA, Montesinos P. Evolving treatment patterns and outcomes in older patients (>= 60 years) with AML: changing everything to change nothing?. LEUKEMIA. 2021. 35(6):1571-1585. DOI: 10.1038/s41375-020-01058-4.

Autores/as: IF: 11,528 Q1 D1

IF: 11,528

IF: 11,528 Q1 D1

Autores/as: Paiva B, Vidriales MB, Sempere A, Tarin F, Colado E, Benavente C, Cedena MT, Sanchez J, Caballero-Velazquez T, Cordon L, Garces JJ, Simoes C, Martinez-Cuadron D, Bernal T, Botella C, Grille S, Serrano J, Rodriguez-Medina C, Algarra L, Alonso-Dominguez JM, Amigo ML, Barrios M, Garcia-Boyero R, Colorado M, Perez-Oteyza J, Perez-Encinas M, Costilla-Barriga L, Sayas MJ, Perez O, Gonzalez-Diaz M, Perez-Simon JA, Martinez-Lopez J, Sossa C, Orfao A, San Miguel JF, Sanz MA, Montesinos P

Título: Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

Revista: LEUKEMIA

DOI: 10.1038/s41375-021-01126-3

Paiva B, Vidriales MB, Sempere A, Tarin F, Colado E, Benavente C, Cedena MT, Sanchez J, Caballero-Velazquez T, Cordon L, Garces JJ, Simoes C, Martinez-Cuadron D, Bernal T, Botella C, Grille S, Serrano J, Rodriguez-Medina C, Algarra L, Alonso-Dominguez JM, Amigo ML, Barrios M, Garcia-Boyero R, Colorado M, Perez-Oteyza J, Perez-Encinas M, Costilla-Barriga L, Sayas MJ, Perez O, Gonzalez-Diaz M, Perez-Simon JA, Martinez-Lopez J, Sossa C, Orfao A, San Miguel JF, Sanz MA, Montesinos P. Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia. LEUKEMIA. 2021. 35(8):2358-2370. DOI: 10.1038/s41375-021-01126-3.

Autores/as: IF: 11,528 Q1 D1

IF: 11,528

IF: 11,528 Q1 D1

Autores/as: Serrano-Lopez J, Hegde S, Kumar S, Serrano J, Fang J, Wellendorf AM, Roche PA, Rangel Y, Carrington LJ, Geiger H, Grimes HL, Luther S, Maillard I, Sanchez-Garcia J, Starczynowski DT, Cancelas JA

Título: Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics

Revista: ELIFE

DOI: 10.7554/eLife.66190

Serrano-Lopez J, Hegde S, Kumar S, Serrano J, Fang J, Wellendorf AM, Roche PA, Rangel Y, Carrington LJ, Geiger H, Grimes HL, Luther S, Maillard I, Sanchez-Garcia J, Starczynowski DT, Cancelas JA. Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics. ELIFE. 2021. 10():-. DOI: 10.7554/eLife.66190.

Autores/as: IF: 8,14 Q1 D1

IF: 8,14

IF: 8,14 Q1 D1

Autores/as: Mingot-Castellano ME, Pardos-Gea J, Haya S, Bastida-Bermejo JM, Tassies D, Marco-Rico A, Nunez R, Garcia-Candel F, De Mora MCFS, Soto I, Alvarez-Roman MT, Asenjo S, Carrasco M, Lluch-Garcia R, Martin-Antoran JM, Rodriguez-Alen A, Rosello E, Torres-Minana L, Marcellini-Antonio S, Moreto-Quinana A, Rodriguez-Garcia JA, Aguinaco-Culebras R, Alonso-Escobar N, Cervero-Santiago C, Fernandez-Mosteirin N, Martinez-Badas MP, Perez-Sanchez M, Perez-Montes R, Rodriguez-Gonzalez R, Uribe-Barrientos M, Caparros-Miranda IS, Iglesias-Fernandez M, Baena A, Rodriguez-Lopez M, Sebrango-Sandia A, Vazquez-Fernandez I, Marco P

Título: Management of acquired hemophilia A: results from the Spanish registry

Revista: BLOOD ADVANCES

DOI: 10.1182/bloodadvances.2021004626

Mingot-Castellano ME, Pardos-Gea J, Haya S, Bastida-Bermejo JM, Tassies D, Marco-Rico A, Nunez R, Garcia-Candel F, De Mora MCFS, Soto I, Alvarez-Roman MT, Asenjo S, Carrasco M, Lluch-Garcia R, Martin-Antoran JM, Rodriguez-Alen A, Rosello E, Torres-Minana L, Marcellini-Antonio S, Moreto-Quinana A, Rodriguez-Garcia JA, Aguinaco-Culebras R, Alonso-Escobar N, Cervero-Santiago C, Fernandez-Mosteirin N, Martinez-Badas MP, Perez-Sanchez M, Perez-Montes R, Rodriguez-Gonzalez R, Uribe-Barrientos M, Caparros-Miranda IS, Iglesias-Fernandez M, Baena A, Rodriguez-Lopez M, Sebrango-Sandia A, Vazquez-Fernandez I, Marco P. Management of acquired hemophilia A: results from the Spanish registry. BLOOD ADVANCES. 2021. 5(19):3821-3829. DOI: 10.1182/bloodadvances.2021004626.

Autores/as: IF: 6,799 Q1 D2

IF: 6,799

IF: 6,799 Q1 D2

Autores/as: Vega-Garcia N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell M, Jimenez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sanchez-Garcia J, Garcia-Calderon CB, Gomez-Casares MT, Martin-Clavero E, Escudero A, Martinez-Gallo MR, Munoz L, Velasco MR, Garcia-Morin M, Catala A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molines A, Guerra-Garcia P, Perez-Martinez A, Garcia-Abos M, Ortiz RR, Pisa S, Adan R, de Heredia CD, Dapena JL, Rives S, Ramirez-Orellana M, Camos M

Título: Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

Revista: FRONTIERS IN PEDIATRICS

DOI: 10.3389/fped.2020.614521

Vega-Garcia N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell M, Jimenez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sanchez-Garcia J, Garcia-Calderon CB, Gomez-Casares MT, Martin-Clavero E, Escudero A, Martinez-Gallo MR, Munoz L, Velasco MR, Garcia-Morin M, Catala A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molines A, Guerra-Garcia P, Perez-Martinez A, Garcia-Abos M, Ortiz RR, Pisa S, Adan R, de Heredia CD, Dapena JL, Rives S, Ramirez-Orellana M, Camos M. Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment. FRONTIERS IN PEDIATRICS. 2021. 8():-. DOI: 10.3389/fped.2020.614521.

Autores/as: IF: 3,418 Q1 D2

IF: 3,418

IF: 3,418 Q1 D2

Autores/as: Simoes C, Paiva B, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez JL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MA, Montesinos P

Título: Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Revista: BLOOD ADVANCES

DOI: 10.1182/bloodadvances.2020003195

IF: 6,686

Simoes C, Paiva B, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez JL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MA, Montesinos P. Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial. BLOOD ADVANCES. 2021. 5(3):760-770. DOI: 10.1182/bloodadvances.2020003195. IF: 6,686 Q1 D2

Autores/as: Sargas C, Ayala R, Chillon MC, Larrayoz MJ, Carrillo-Cruz E, Bilbao C, Yebenes-Ramirez M, Llop M, Rapado I, Garcia-Sanz R, Vazquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martinez-Cuadron D, Bergua J, Amigo ML, Martinez-Sanchez P, Tormo M, Bernal T, Herrera-Puente P, Garcia R, Algarra L, Sayas MJ, Costilla-Barriga L, Perez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Dominguez JM, Sanz MA, Sanchez-Garcia J, Gomez-Casares MT, Perez-Simon JA, Calasanz MJ, Gonzalez-Diaz M, Martinez-Lopez J, Barragan E, Montesinos P

Título: Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project

Revista: HAEMATOLOGICA

DOI: 10.3324/haematol.2020.263806

Sargas C, Ayala R, Chillon MC, Larrayoz MJ, Carrillo-Cruz E, Bilbao C, Yebenes-Ramirez M, Llop M, Rapado I, Garcia-Sanz R, Vazquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martinez-Cuadron D, Bergua J, Amigo ML, Martinez-Sanchez P, Tormo M, Bernal T, Herrera-Puente P, Garcia R, Algarra L, Sayas MJ, Costilla-Barriga L, Perez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Dominguez JM, Sanz MA, Sanchez-Garcia J, Gomez-Casares MT, Perez-Simon JA, Calasanz MJ, Gonzalez-Diaz M, Martinez-Lopez J, Barragan E, Montesinos P. Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project. HAEMATOLOGICA. 2021. 106(12):3079-3089. DOI: 10.3324/haematol.2020.263806.

Autores/as: IF: 9,941 Q1 D2

IF: 9,941

IF: 9,941 Q1 D2

Autores/as: Castano-Bonilla T, Alonso-Dominguez JM, Barragan E, Rodriguez-Veiga R, Sargas C, Gil C, Chillon C, Vidriales MB, Garcia R, Martinez-Lopez J, Ayala R, Larrayoz MJ, Anguita E, Cuello R, Cantalapiedra A, Carrillo E, Soria-Saldise E, Labrador J, Recio I, Algarra L, Rodriguez-Medina C, Bilbao-Syeiro C, Lopez-Lopez JA, Serrano J, De Cabo E, Sayas MJ, Olave MT, Sanchez-Garcia J, Mateos M, Blas C, Lopez-Lorenzo JL, Lainez-Gonzalez D, Serrano J, Martinez-Cuadron D, Sanz MA, Montesinos P

Título: Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

Revista: SCIENTIFIC REPORTS

DOI: 10.1038/s41598-021-00050-x

Castano-Bonilla T, Alonso-Dominguez JM, Barragan E, Rodriguez-Veiga R, Sargas C, Gil C, Chillon C, Vidriales MB, Garcia R, Martinez-Lopez J, Ayala R, Larrayoz MJ, Anguita E, Cuello R, Cantalapiedra A, Carrillo E, Soria-Saldise E, Labrador J, Recio I, Algarra L, Rodriguez-Medina C, Bilbao-Syeiro C, Lopez-Lopez JA, Serrano J, De Cabo E, Sayas MJ, Olave MT, Sanchez-Garcia J, Mateos M, Blas C, Lopez-Lorenzo JL, Lainez-Gonzalez D, Serrano J, Martinez-Cuadron D, Sanz MA, Montesinos P. Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens. SCIENTIFIC REPORTS. 2021. 11(1):-. DOI: 10.1038/s41598-021-00050-x.

Autores/as: IF: 4,38 Q1 D3

IF: 4,38

IF: 4,38 Q1 D3

Autores/as: Abrisqueta P, Loscertales J, Terol MJ, Payer AR, Ortiz M, Perez I, Cuellar-Garcia C, de la Mata MF, Rodriguez A, Lario A, Delgado J, Godoy A, Perez JMA, Berruezo MJ, Oliveira A, Hernandez-Rivas JA, Malo MDG, Medina A, Martin PG, Osorio S, Baltasar P, Fernandez-Zarzoso M, Marco F, Mancenido MJV, Simonovich AS, Rubio ML, Jarque I, Suarez A, Alvarez RF, Anchel AL, Rios E, Castillo MDL, Persona EP, Munoz RG, Ramos R, Yanez L, Bello JL, Loriente C, Acha D, Villanueva M

Título: Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)

Revista: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

DOI: 10.1016/j.clml.2021.07.022

Abrisqueta P, Loscertales J, Terol MJ, Payer AR, Ortiz M, Perez I, Cuellar-Garcia C, de la Mata MF, Rodriguez A, Lario A, Delgado J, Godoy A, Perez JMA, Berruezo MJ, Oliveira A, Hernandez-Rivas JA, Malo MDG, Medina A, Martin PG, Osorio S, Baltasar P, Fernandez-Zarzoso M, Marco F, Mancenido MJV, Simonovich AS, Rubio ML, Jarque I, Suarez A, Alvarez RF, Anchel AL, Rios E, Castillo MDL, Persona EP, Munoz RG, Ramos R, Yanez L, Bello JL, Loriente C, Acha D, Villanueva M. Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study). CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2021. 21(12):E985-E999. DOI: 10.1016/j.clml.2021.07.022.

Autores/as: IF: 3,231 Q3

IF: 3,231

IF: 3,231 Q3

Autores/as: Murillo-Sanjuan L, Gonzalez-Vicent M, Aparicio BA, Serra IB, Villa AR, Oficialdegui MLU, Lopez-Duarte M, Belendez-Bieler C, Urgelles AS, Navarro JS, Diaz-de-Heredia C

Título: Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children

Revista: BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-020-01172-y

IF: 5,483

Murillo-Sanjuan L, Gonzalez-Vicent M, Aparicio BA, Serra IB, Villa AR, Oficialdegui MLU, Lopez-Duarte M, Belendez-Bieler C, Urgelles AS, Navarro JS, Diaz-de-Heredia C. Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children. BONE MARROW TRANSPLANTATION. 2021. 56(5):1213-1216. DOI: 10.1038/s41409-020-01172-y. IF: 5,483 Q1 D3

Autores/as: Ayala R, Rapado I, Onecha E, Martinez-Cuadron D, Carreno-Tarragona G, Bergua JM, Vives S, Algarra JL, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lorenzo JLL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Paiva B, Barragan E, Prosper F, Sanz MA, Martinez-Lopez J, Montesinos P

Título: The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial

Revista: CANCERS

DOI: 10.3390/cancers13102458

Ayala R, Rapado I, Onecha E, Martinez-Cuadron D, Carreno-Tarragona G, Bergua JM, Vives S, Algarra JL, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lorenzo JLL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Paiva B, Barragan E, Prosper F, Sanz MA, Martinez-Lopez J, Montesinos P. The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial. CANCERS. 20 13(10):-. DOI: 10.3390/cancers13102458.

Autores/as: IF: 6,639 Q1 D3

IF: 6,639

IF: 6,639 Q1 D3

Título: Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses

Revista: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

DOI: 10.1161/ATVBAHA.120.315346

Autores/as: IF: 8,311 Q1 D1

IF: 8,311

IF: 8,311 Q1 D1

Título: A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia

Revista: CANCER

DOI: 10.1002/cncr.33403

Autores/as: IF: 6,86 Q1 D2

IF: 6,86

IF: 6,86 Q1 D2

Título: Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

Revista: BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-021-01264-

Autores/as: IF: 5,483 Q1 D3

IF: 5,483

IF: 5,483 Q1 D3

Título: Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group

Revista: LEUKEMIA & LYMPHOMA

DOI: 10.1080/10428192021.1948031

Autores/as: IF: 3,28 Q3

IF: 3,28

IF: 3,28 Q3

Título: Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia

Revista: BLOOD

DOI: 10.1182/blood.2020007311

Autores/as: IF: 22,113 Q1 D1

IF: 22,113

IF: 22,113 Q1 D1

Título: Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study

Revista: BRITISH JOURNAL OF HAEMATOLOGY

DOI: 10.1111/bjh.16741

Autores/as: IF: 6,998 Q1 D2

IF: 6,998

IF: 6,998 Q1 D2

Título: Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment

Revista: BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-020-01157-x

Autores/as: IF: 5,483 Q1 D3

IF: 5,483

IF: 5,483 Q1 D3

Título: Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients

Revista: ANNALS OF HEMATOLOGY

DOI: 10.1007/s00277-020-04360-4

Autores/as: IF: 3,673 Q2 D5

IF: 3,673

IF: 3,673 Q2 D5

Autores/as: Rodriguez DC, Urain TA, Rodriguez AC, Torres EG, Vicent MG, Garcia GG, Garcia AR, Hidalgo MC, Villacampa A

Revista: JOURNAL OF MEDICAL ECONOMICS

DOI: 10.1080/13696998.2021.191674

Autores/as: IF: 2,448 Q2 D5

IF: 2,448

IF: 2,448 Q2 D5

Título: Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)

Revista: EUROPEAN JOURNAL OF HAEMATOLOGY

DOI: 1111/ejh.13618

IF: 2,997

Título: Evolving treatment patterns and outcomes in older patients (>= 60 years) with AML: changing everything to change nothing?

Revista: LEUKEMIA

DOI: 10.1038/s41375-020-01058-4

Autores/as: IF: 11,528 Q1 D1

IF: 11,528

IF: 11,528 Q1 D1

Título: Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

Revista: LEUKEMIA

DOI: 10.1038/s41375-021-01126-3

Autores/as: IF: 11,528 Q1 D1

IF: 11,528

IF: 11,528 Q1 D1

Título: Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics

Revista: ELIFE

DOI: 10.7554/eLife.66190

Autores/as: IF: 8,14 Q1 D1

IF: 8,14

IF: 8,14 Q1 D1

Título: Management of acquired hemophilia A: results from the Spanish registry

Revista: BLOOD ADVANCES

DOI: 10.1182/bloodadvances.2021004626

Autores/as: IF: 6,799 Q1 D2

IF: 6,799

IF: 6,799 Q1 D2

Revista: FRONTIERS IN PEDIATRICS

DOI: 10.3389/fped.2020.614521

Autores/as: IF: 3,418 Q1 D2

IF: 3,418

IF: 3,418 Q1 D2

Título: Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Revista: BLOOD ADVANCES

DOI: 10.1182/bloodadvances.2020003195

IF: 6,686

Título: Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project

Revista: HAEMATOLOGICA

DOI: 10.3324/haematol.2020.263806

Autores/as: IF: 9,941 Q1 D2

IF: 9,941

IF: 9,941 Q1 D2

Título: Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

Revista: SCIENTIFIC REPORTS

DOI: 10.1038/s41598-021-00050-x

Autores/as: IF: 4,38 Q1 D3

IF: 4,38

IF: 4,38 Q1 D3

Título: Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)

Revista: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

DOI: 10.1016/j.clml.2021.07.022

Autores/as: IF: 3,231 Q3

IF: 3,231

IF: 3,231 Q3

Autores/as: Murillo-Sanjuan L, Gonzalez-Vicent M, Aparicio BA, Serra IB, Villa AR, Oficialdegui MLU, Lopez-Duarte M, Belendez-Bieler C, Urgelles AS, Navarro JS, Diaz-de-Heredia C

Revista: BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-020-01172-y

IF: 5,483

Título: The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial

Revista: CANCERS

DOI: 10.3390/cancers13102458

Autores/as: IF: 6,639 Q1 D3

IF: 6,639

IF: 6,639 Q1 D3

Publicaciones 2020

Autores/as: Sitges M, Boluda B, Garrido A, Morgades M, Granada I, Barragan E, Arnan M, Serrano J, Tormo M, Bergua JM, Colorado M, Salamero O, Esteve J, Benavente C, Perez-Encinas M, Coll R, Marti-Tutusaus JM, Brunet S, Sierra J, Sanz MA, Montesinos P, Ribera JM, Vive

Título: Acute myeloid leukemia with inv(3)(q21

Revista: 3q26

DOI: 10.1111/ejh.13417

Sitges M, Boluda B, Garrido A, Morgades M, Granada I, Barragan E, Arnan M, Serrano J, Tormo M, Bergua JM, Colorado M, Salamero O, Esteve J, Benavente C, Perez-Encinas M, Coll R, Marti-Tutusaus JM, Brunet S, Sierra J, Sanz MA, Montesinos P, Ribera JM, Vive. Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols. EUROPEAN JOURNAL OF HAEMATOLOGY. 2020. 105 (2):138-147 DOI: 10.1111/ejh.13417

Autores/as: IF: 2,22 Q: 3

IF: 2,22

IF: 2,22 Q: 3

Autores/as: Valhondo I, Hassouneh F, Lopez-Sejas N, Pera A, Sanchez-Correa B, Guerrero B, Bergua JM, Arcos MJ, Banas H, Casas-Aviles I, Sanchez-Garcia J, Serrano J, Martin C, Duran E, Alonso C, Solana R, Tarazona R

Título: Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia

Revista: CANCERS

DOI: 10.3390/cancers12082171

Valhondo I, Hassouneh F, Lopez-Sejas N, Pera A, Sanchez-Correa B, Guerrero B, Bergua JM, Arcos MJ, Banas H, Casas-Aviles I, Sanchez-Garcia J, Serrano J, Martin C, Duran E, Alonso C, Solana R, Tarazona R. Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia. CANCERS. 2020. 12 (8):- DOI: 10.3390/cancers12082171

Autores/as: IF: 6,126 Q: 1

IF: 6,126

IF: 6,126 Q: 1

Título: Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study

Revista: BRITISH JOURNAL OF HAEMATOLOGY

DOI: 10.1111/bjh.16741

Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Seoane CP, Jimenez JL, Garcia-Cosio M, Caballero D, Munez OJB, Carpio C, Castellvi J, Pozo AM, Farre BG, Bendana A, Aliste C, Gonzalez AJ, de Villambrosia SG, Piris MA, Codina JG, Mayordomo-A. Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study. BRITISH JOURNAL OF HAEMATOLOGY. 2020. 192 (1):82-99 DOI: 10.1111/bjh.16741

Autores/as: IF: 5,518 Q: 1

IF: 5,518

IF: 5,518 Q: 1

Autores/as: Gudiol C, Albasanz-Puig A, Laporte-Amargos J, Pallares N, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martin-Davila P, Herrera F, Gasch O, Drgona L, Morales HP, Brunel AS, Garcia E, Isler B, Kern WV, M

Título: Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa

Revista: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

DOI: 10.1128/AAC.02494-19

Gudiol C, Albasanz-Puig A, Laporte-Amargos J, Pallares N, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martin-Davila P, Herrera F, Gasch O, Drgona L, Morales HP, Brunel AS, Garcia E, Isler B, Kern WV, M. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2020. 64 (4):- DOI: 10.1128/AAC.02494-19

Autores/as: IF: 4,904 Q: 1

IF: 4,904

IF: 4,904 Q: 1

Autores/as: Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garces C, Alonso J, Barragan E, Fernandez G, Hernandez-Sanchez JM, Martin-Izquierdo M, Maynou J, Minguela A, Montano A, Ortega M, Torrebadell M, Cervera J, Sanchez J, Jimenez-Velasco A, Riesco S, Hernandez-Rivas JM, Lassaletta A, Fernandez JM, Rives S, Dapena JL, Ramirez M, Camos M

Título: Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

Revista: JOURNAL OF PERSONALIZED MEDICINE

DOI: 10.3390/jpm10040244

Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garces C, Alonso J, Barragan E, Fernandez G, Hernandez-Sanchez JM, Martin-Izquierdo M, Maynou J, Minguela A, Montano A, Ortega M, Torrebadell M, Cervera J, Sanchez J, Jimenez-Velasco A, Riesco S, Hernandez-Rivas JM, Lassaletta A, Fernandez JM, Rives S, Dapena JL, Ramirez M, Camos M. Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia. JOURNAL OF PERSONALIZED MEDICINE. 2020. 10 (4):- DOI: 10.3390/jpm10040244

Autores/as: IF: 4,433 Q: 1 D: 1

IF: 4,433

IF: 4,433 Q: 1 D: 1

Autores/as: De Mier MVPR, Ojeda R, Alvarez-Lara MA, Navas A, Alonso C, Caballero-Villarraso J, Aljama P, Alvarez MA, Soriano S, Rodriguez M, Martin-Malo A

Título: Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients

Revista: BMC NEPHROLOGY

DOI: 10.1186/s12882-020-01885-8

De Mier MVPR, Ojeda R, Alvarez-Lara MA, Navas A, Alonso C, Caballero-Villarraso J, Aljama P, Alvarez MA, Soriano S, Rodriguez M, Martin-Malo A. Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients. BMC NEPHROLOGY. 2020. 21 (1):227- DOI: 10.1186/s12882-020-01885-8

Autores/as: IF: 1,913 Q: 3

IF: 1,913

IF: 1,913 Q: 3

Autores/as: Serrano-Lopez J, Fernández JL, Lumbreras E, Serrano J, Martinez-Losada C, Martin C, Hernandez-Rivas JM, Sanchez-Garcia J

Título: Machine learning applied to gene expression analysis of T-lymphocytes in patients with cGVHD

Revista: BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-020-0848-y

Serrano-Lopez J, Fernández JL, Lumbreras E, Serrano J, Martinez-Losada C, Martin C, Hernandez-Rivas JM, Sanchez-Garcia J. Machine learning applied to gene expression analysis of T-lymphocytes in patients with cGVHD. BONE MARROW TRANSPLANTATION. 2020. 55 (8):1668-1670 DOI: 10.1038/s41409-020-0848-y

Autores/as: IF: 4,725 Q: 1

IF: 4,725

IF: 4,725 Q: 1

Autores/as: Rodriguez-Medina C, Martínez-Cuadron D, Cano I, Gil C, Tormo M, Martinez-Sanchez MD, del Castillo TB, Serrano-Lopez J, Benavente C, Herrera-Puente P, Garcia-Boyero R, Lavilla-Rubira E, Amigo ML, Sayas-Llorisn MJ, Bergua-Burgues JM, Perez-Simon JA, Rodrigu

Título: Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study

Revista: LEUKEMIA RESEARCH

DOI: 10.1016/j.leukres.2020.106352

Rodriguez-Medina C, Martínez-Cuadron D, Cano I, Gil C, Tormo M, Martinez-Sanchez MD, del Castillo TB, Serrano-Lopez J, Benavente C, Herrera-Puente P, Garcia-Boyero R, Lavilla-Rubira E, Amigo ML, Sayas-Llorisn MJ, Bergua-Burgues JM, Perez-Simon JA, Rodrigu. Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study. LEUKEMIA RESEARCH. 2020. 92 ():- DOI: 10.1016/j.leukres.2020.106352

Autores/as: IF: 2,214 Q: 3

IF: 2,214

IF: 2,214 Q: 3

Autores/as: Mira E, Yarce OA, Ortega C, Fernandez S, Pascual NM, Gomez C, Alvarez MA, Molina IJ, Lama R, Santamaria M

Título: Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma

Revista: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

DOI: 10.1016/j.jaip.2020.06.046

Mira E, Yarce OA, Ortega C, Fernandez S, Pascual NM, Gomez C, Alvarez MA, Molina IJ, Lama R, Santamaria M. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2020. 8 (8):2793-2795 DOI: 10.1016/j.jaip.2020.06.046

Autores/as: IF: 7,574 Q: 1

IF: 7,574

IF: 7,574 Q: 1

Autores/as: Ribera JM, Garcia O, Chapchap EC, Gil C, Gonzalez-Campos J, Barba P, Amigo ML, Moreno MJ, Lavilla E, Alonso N, Bergua JM, Tormo M, Ribera J, Sierra M, Martinez-Carballeira D, Mercadal S, Hernandez-Rivas JM, Vall-Llovera F, Genesca E, Cladera A, Novo A, Ab

Título: Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy

Revista: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

DOI: 10.1016/j.clml.2020.03.011

Ribera JM, Garcia O, Chapchap EC, Gil C, Gonzalez-Campos J, Barba P, Amigo ML, Moreno MJ, Lavilla E, Alonso N, Bergua JM, Tormo M, Ribera J, Sierra M, Martinez-Carballeira D, Mercadal S, Hernandez-Rivas JM, Vall-Llovera F, Genesca E, Cladera A, Novo A, Ab. Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2020. 20 (8):E513-e522 DOI: 10.1016/j.clml.2020.03.011

Autores/as: IF: 2,298 Q: 3

IF: 2,298

IF: 2,298 Q: 3

Publicaciones 2019

Autores/as: Martinez-Cuadron D, Gil C, Serrano J, Rodriguez G, Perez-Oteyza J, Garcia-Boyero R, Jimenez-Bravo S, Vives S, Vidriales MB, Lavilla E, Perez-Simon JA, Tormo M, Colorado M, Bergua J, Lopez JA, Herrera P, Hernandez-Campo P, Gorrochategui J, Primo D, Rojas J; A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients

Título: LEUKEMIA RESEARCH

Revista: 2019 Jan;76:1-10

DOI: 10.1016/j.leukres.2018.11.006

Martinez-Cuadron D, Gil C, Serrano J, Rodriguez G, Perez-Oteyza J, Garcia-Boyero R, Jimenez-Bravo S, Vives S, Vidriales MB, Lavilla E, Perez-Simon JA, Tormo M, Colorado M, Bergua J, Lopez JA, Herrera P, Hernandez-Campo P, Gorrochategui J, Primo D, Rojas J; A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients. LEUKEMIA RESEARCH. 2019 Jan;76:1-10. doi: 10.1016/j.leukres.2018.11.006.

Autores/as: IF: 2,066 Q3

IF: 2,066

IF: 2,066 Q3

Autores/as: Sobas M, Montesinos P, Boluda B, Bernal T, Vellenga E, Nomdedeu J, Gonzalez-Campos J, Chillon M, Holowiecka A, Esteve J, Bergua J, Gonzalez-Sanmiguel JD, Gil-Cortes C, Tormo M, Salamero O, Manso F, Fernandez I, de la Serna J, Moreno MJ, Perez-Encinas M, K; An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

Título: LEUKEMIA & LYMPHOMA

Revista: 2019 Apr;60(4):1030-1035

DOI: 10.1080/10428194.2018.1516875

Sobas M, Montesinos P, Boluda B, Bernal T, Vellenga E, Nomdedeu J, Gonzalez-Campos J, Chillon M, Holowiecka A, Esteve J, Bergua J, Gonzalez-Sanmiguel JD, Gil-Cortes C, Tormo M, Salamero O, Manso F, Fernandez I, de la Serna J, Moreno MJ, Perez-Encinas M, K; An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens. LEUKEMIA & LYMPHOMA. 2019 Apr;60(4):1030-1035. doi: 10.1080/10428194.2018.1516875.

Autores/as: IF: 2,674 Q: 3

IF: 2,674

IF: 2,674 Q: 3

Autores/as: Megias-Vericat JE, Martinez-Cuadron D, Lopez JM, Bergua JM, Tormo M, Serrano J, Gonzalez A, de Oteyza JP, Vives S, Vidriales B, Herrera P, Vera JA, Martinez AL, de la Fuente A, Amador ML, Hernandez-Rivas JA, Fernandez MA, Cervero CJ, Morino D, Campo PH, G; Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia

Título: MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

Revista: 2019 Mar 1;11(1):e2019016

DOI: 10.4084/MJHID.2019.016

Megias-Vericat JE, Martinez-Cuadron D, Lopez JM, Bergua JM, Tormo M, Serrano J, Gonzalez A, de Oteyza JP, Vives S, Vidriales B, Herrera P, Vera JA, Martinez AL, de la Fuente A, Amador ML, Hernandez-Rivas JA, Fernandez MA, Cervero CJ, Morino D, Campo PH, G; Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES. 2019 Mar 1;11(1):e2019016. doi: 10.4084/MJHID.2019.016.

Autores/as: IF: 1,586 Q: 4

IF: 1,586

IF: 1,586 Q: 4

Autores/as: Garcia-Cadenas I, Yanez L, Jarque I, Martino R, Perez-Simon JA, Valcarcel D, Sanz J, Bermudez A, Munoz C, Calderon-Cabrera C, Garcia E, Alonso L, Suarez-Lledo M, Gonzalez Vicent M, Heras I, Viguria MC, Batlle M, Vazquez L, Lopez J, Solano C; Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)

Título: EUROPEAN JOURNAL OF HAEMATOLOGY

Revista: 2019 Jun;102(6):465-471

DOI: 10.1111/ejh.13226

Garcia-Cadenas I, Yanez L, Jarque I, Martino R, Perez-Simon JA, Valcarcel D, Sanz J, Bermudez A, Munoz C, Calderon-Cabrera C, Garcia E, Alonso L, Suarez-Lledo M, Gonzalez Vicent M, Heras I, Viguria MC, Batlle M, Vazquez L, Lopez J, Solano C; Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH). EUROPEAN JOURNAL OF HAEMATOLOGY. 2019 Jun;102(6):465-471. doi: 10.1111/ejh.13226.

Autores/as: IF: 2,217 Q: 3

IF: 2,217

IF: 2,217 Q: 3

Autores/as: Alonso L, Gonzalez-Vicent M, Belendez C, Badell I, Sastre A, Rodriguez-Villa A, Bermudez-Cortes M, Hladun R, de Heredia CD; Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON)

Título: MEDICINA CLINICA

Revista: 2019 Feb 15;152(4):135-140

DOI: 10.1016/j.medcli.2018.05.013

Alonso L, Gonzalez-Vicent M, Belendez C, Badell I, Sastre A, Rodriguez-Villa A, Bermudez-Cortes M, Hladun R, de Heredia CD; Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON). MEDICINA CLINICA. 2019 Feb 15;152(4):135-140. doi: 10.1016/j.medcli.2018.05.013.

Autores/as: IF: 1,277 Q: 3

IF: 1,277

IF: 1,277 Q: 3

Autores/as: Martos L, Fernandez-Pardo A, Lopez-Fernandez MF, Ibanez F, Herrero S, Tassies D, Gonzalez-Porras JR, Solmoirago MJ, Costa MJ, Reverter JC, Marco P, Roldan V, Lecumberri R, Velasco F, Oto J, Iruin G, Alonso MN, Vaya A, Bonanad S, Ferrando F, Marti E, Cid A; Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency

Título: THROMBOSIS AND HAEMOSTASIS

Revista: 2019 Sep;119(9):1409-1418

DOI: 10.1055/s-0039-1692440

Martos L, Fernandez-Pardo A, Lopez-Fernandez MF, Ibanez F, Herrero S, Tassies D, Gonzalez-Porras JR, Solmoirago MJ, Costa MJ, Reverter JC, Marco P, Roldan V, Lecumberri R, Velasco F, Oto J, Iruin G, Alonso MN, Vaya A, Bonanad S, Ferrando F, Marti E, Cid A; Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency. THROMBOSIS AND HAEMOSTASIS. 2019 Sep;119(9):1409-1418. doi: 10.1055/s-0039-1692440.

Autores/as: IF: 4,733 Q: 1

IF: 4,733

IF: 4,733 Q: 1

Autores/as: Albasanz-Puig A, Gudiol C, Parody R, Tebe C, Akova M, Araos R, Bote A, Brunel AS, Calik S, Drgona L, Garcia E, Hemmati P, Herrera F, Ibrahim KY, Isler B, Kanj S, Kern W, de la Calle GM, Manzur A, Marin JI, Marquez-Gomez I, Martin-Davila P, Mikulska M, Mon; Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study

Título: BMJ OPEN

Revista: 2019 May 24;9(5):e025744

DOI: 10.1136/bmjopen-2018-025744

Albasanz-Puig A, Gudiol C, Parody R, Tebe C, Akova M, Araos R, Bote A, Brunel AS, Calik S, Drgona L, Garcia E, Hemmati P, Herrera F, Ibrahim KY, Isler B, Kanj S, Kern W, de la Calle GM, Manzur A, Marin JI, Marquez-Gomez I, Martin-Davila P, Mikulska M, Mon; Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study. BMJ OPEN. 2019 May 24;9(5):e025744. doi: 10.1136/bmjopen-2018-025744.

Autores/as: IF: 2,413 Q: 2

IF: 2,413

IF: 2,413 Q: 2

Autores/as: Ribera JM, Garcia O, Moreno MJ, Barba P, Garcia-Cadenas I, Mercadal S, Montesinos P, Barrios M, Gonzalez-Campos J, Martinez-Carballeira D, Gil C, Ribera J, Vives S, Novo A, Cervera M, Serrano J, Lavilla E, Abella E, Tormo M, Amigo ML, Artola MT, Genesca E; Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group

Título: CANCER

Revista: 2019 Aug 15;125(16):2810-2817

DOI: 10.1002/cncr.32156

Ribera JM, Garcia O, Moreno MJ, Barba P, Garcia-Cadenas I, Mercadal S, Montesinos P, Barrios M, Gonzalez-Campos J, Martinez-Carballeira D, Gil C, Ribera J, Vives S, Novo A, Cervera M, Serrano J, Lavilla E, Abella E, Tormo M, Amigo ML, Artola MT, Genesca E; Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group. CANCER. 2019 Aug 15;125(16):2810-2817. doi: 10.1002/cncr.32156.

Autores/as: IF: 6,102 Q: 1

IF: 6,102

IF: 6,102 Q: 1

Autores/as: Revilla N, Corral J, Minano A, Mingot-Castellano ME, Campos RM, Velasco F, Gonzalez N, Galvez E, Berrueco R, Fuentes I, Gonzalez-Lopez TJ, de la Morena-Barrio ME, Gonzalez-Porras JR, Vicente V, Lozano ML; Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content

Título: PLATELETS

Revista: 2019;30(6):743-751

DOI: 10.1080/09537104.2018.1513476

Revilla N, Corral J, Minano A, Mingot-Castellano ME, Campos RM, Velasco F, Gonzalez N, Galvez E, Berrueco R, Fuentes I, Gonzalez-Lopez TJ, de la Morena-Barrio ME, Gonzalez-Porras JR, Vicente V, Lozano ML; Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content. PLATELETS. 2019;30(6):743-751. doi: 10.1080/09537104.2018.1513476.

Autores/as: IF: 3,106 Q: 2

IF: 3,106

IF: 3,106 Q: 2

Autores/as: Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germin; Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia

Título: LEUKEMIA & LYMPHOMA

Revista: 2019 Jan;60(1):246-249

DOI: 10.1080/10428194.2018.1468893

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germin; Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia. LEUKEMIA & LYMPHOMA. 2019 Jan;60(1):246-249. doi: 10.1080/10428194.2018.1468893.

Autores/as: IF: 2,674 Q: 3

IF: 2,674

IF: 2,674 Q: 3

Autores/as: Rodriguez-Veiga R, Montesinos P, Garcia E, Boluda B, Rojas R, Serrano J, Martinez-Cuadron D, Martin C, Sanz J, Tabares S, Pinana JL, Lorenzo I, Montoro J, Salavert M, Peman J, Jarque I, Solves P, Sanz GF, Torres A, Sanz MA; Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients

Título: MYCOSES

Revista: 2019 May;62(5):418-427

DOI: 10.1111/myc.12891

Rodriguez-Veiga R, Montesinos P, Garcia E, Boluda B, Rojas R, Serrano J, Martinez-Cuadron D, Martin C, Sanz J, Tabares S, Pinana JL, Lorenzo I, Montoro J, Salavert M, Peman J, Jarque I, Solves P, Sanz GF, Torres A, Sanz MA; Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients. MYCOSES. 2019 May;62(5):418-427. doi: 10.1111/myc.12891.

Autores/as: IF: 3,065 Q: 2

IF: 3,065

IF: 3,065 Q: 2

Autores/as: Bento L, Bastida JM, Garcia-Cadenas I, Garcia-Torres E, Rivera D, Bosch-Vilaseca A, De Miguel C, Martinez-Munoz ME, Fernandez-Aviles F, Roldan E, Chinea A, Yanez L, Zudaire T, Vaz CP, Espigado I, Lopez J, Valcarcel D, Duarte R, Cabrera R, Herrera C, Gonza

Título: Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant; Real life outcomes of patients aged >= 75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry

Revista: LEUKEMIA & LYMPHOMA

DOI: 10.1080/10428194.2019.1607327

Bento L, Bastida JM, Garcia-Cadenas I, Garcia-Torres E, Rivera D, Bosch-Vilaseca A, De Miguel C, Martinez-Munoz ME, Fernandez-Aviles F, Roldan E, Chinea A, Yanez L, Zudaire T, Vaz CP, Espigado I, Lopez J, Valcarcel D, Duarte R, Cabrera R, Herrera C, Gonza. Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant; Real life outcomes of patients aged >= 75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry. LEUKEMIA & LYMPHOMA. 2019 Nov;60(11):2720-2732. doi: 10.1080/10428194.2019.1607327.

Autores/as: IF: 2,674 Q: 3

IF: 2,674

IF: 2,674 Q: 3

Publicaciones 2018

Autores/as: Martinez-Losada C, Serrano-Lopez J, Serrano-Lopez J, Noguera NI, Garza E, Piredda L, Lavorgna S, Consalvo MAI, Ottone T, Alfonso V, Peinado JR, Garcia-Ortiz MV, Morales-Ruiz T, Jerez A, Hurtado AM, Montesinos P, Cervera J, Such E, Ibanez M, Sempere A, Sanz MA, Lo-Coco F, Sanchez-Garcia J

Título: Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes

Revista: HAEMATOLOGICA

Martinez-Losada C, Serrano-Lopez J, Serrano-Lopez J, Noguera NI, Garza E, Piredda L, Lavorgna S, Consalvo MAI, Ottone T, Alfonso V, Peinado JR, Garcia-Ortiz MV, Morales-Ruiz T, Jerez A, Hurtado AM, Montesinos P, Cervera J, Such E, Ibanez M, Sempere A, Sanz MA, Lo-Coco F, Sanchez-Garcia J. Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes. HAEMATOLOGICA. 2018; 103(9):E400-E403.

Autores/as: IF: 9,09 Q: 1 D: 1

IF: 9,09

IF: 9,09 Q: 1 D: 1

Autores/as: Sanchez-Garcia J, Falantes J, Perez AM, Hernandez-Mohedo F, Hermosin L, Torres-Sabariego A, Bailen A, Hernandez-Sanchez JM, Rodriguez MS, Casano FJ, Calderon C, Labrador M, Vahi M, Serrano J, Lumbreras E, Hernandez-Rivas JM

Título: Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia

Revista: LEUKEMIA & LYMPHOMA

Sanchez-Garcia J, Falantes J, Perez AM, Hernandez-Mohedo F, Hermosin L, Torres-Sabariego A, Bailen A, Hernandez-Sanchez JM, Rodriguez MS, Casano FJ, Calderon C, Labrador M, Vahi M, Serrano J, Lumbreras E, Hernandez-Rivas JM. Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia. LEUKEMIA & LYMPHOMA. 2018; 59(5):1095-1104.

Autores/as: IF: 2,644 Q: 2

IF: 2,644

IF: 2,644 Q: 2

Autores/as: Perez-Sanchez C, Arias-de la Rosa I, Aguirre MA, Luque-Tevar M, Ruiz-Limon P, Barbarroja N, Jimenez-Gomez Y, Abalos-Aguilera MC, Collantes-Estevez E, Segui P, Velasco F, Herranz MT, Lozano-Herrero J, Hernandez-Vidal MJ, Martinez C, Gonzalez-Conejero R, Radin M, Sciascia S, Cecchi I, Cuadrado MJ, Lopez-Pedrera C

Título: Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome

Revista: HAEMATOLOGICA

Perez-Sanchez C, Arias-de la Rosa I, Aguirre MA, Luque-Tevar M, Ruiz-Limon P, Barbarroja N, Jimenez-Gomez Y, Abalos-Aguilera MC, Collantes-Estevez E, Segui P, Velasco F, Herranz MT, Lozano-Herrero J, Hernandez-Vidal MJ, Martinez C, Gonzalez-Conejero R, Radin M, Sciascia S, Cecchi I, Cuadrado MJ, Lopez-Pedrera C. Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome. HAEMATOLOGICA. 2018; 103(5):908-918.

Autores/as: IF: 9,09 Q: 1 D: 1

IF: 9,09

IF: 9,09 Q: 1 D: 1

Autores/as: Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Majhail N, Barnard J, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Kobbe G, Bergua J, Serrano J, Gore SD, Zeidan AM

Título: Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study

Revista: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Majhail N, Barnard J, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Kobbe G, Bergua J, Serrano J, Gore SD, Zeidan AM. Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2018; 24(8):1754-1758.

Autores/as: IF: 4,484 Q: 1

IF: 4,484

IF: 4,484 Q: 1

Autores/as: de la Fuente FDA, Duran MS, Alvarez MA, Sanroman IL, Dios AM, Tamayo RR, Garcia R, Gonzalez MS, Prieto E, Barez A, Escalante F, Tejedor A, Ballesteros M, Cabanas V, Capote FJ, Couto C, Garzon S, Gonzalez-Pardo M, Manteca MVM

Título: Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation

Revista: SEMINARS IN HEMATOLOGY

de la Fuente FDA, Duran MS, Alvarez MA, Sanroman IL, Dios AM, Tamayo RR, Garcia R, Gonzalez MS, Prieto E, Barez A, Escalante F, Tejedor A, Ballesteros M, Cabanas V, Capote FJ, Couto C, Garzon S, Gonzalez-Pardo M, Manteca MVM. Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation. SEMINARS IN HEMATOLOGY. 2018; 55(4):189-196.

Autores/as: IF: 3,926 Q: 2

IF: 3,926

IF: 3,926 Q: 2

Autores/as: Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard JD, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Fathi AT, Roboz GJ, Fenaux P, Litzow MR, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua JM, Serrano J, Gore SD, Zeidan AM

Título: Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

Revista: BLOOD ADVANCES

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard JD, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Fathi AT, Roboz GJ, Fenaux P, Litzow MR, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua JM, Serrano J, Gore SD, Zeidan AM. Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort. BLOOD ADVANCES. 2018; 2(8):923-932.

Autores/as: Martinez-Cuadron D, Boluda B, Martinez P, Bergua J, Rodriguez-Veiga R, Esteve J, Vives S, Serrano J, Vidriales B, Salamero O, Cordon L, Sempere A, Jimenez-Ubieto A, Prieto-Delgado J, Diaz-Beya M, Garrido A, Benavente C, Perez-Simon JA, Moscardo F, Sanz MA, Montesinos P

Título: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

Revista: ANNALS OF HEMATOLOGY

Martinez-Cuadron D, Boluda B, Martinez P, Bergua J, Rodriguez-Veiga R, Esteve J, Vives S, Serrano J, Vidriales B, Salamero O, Cordon L, Sempere A, Jimenez-Ubieto A, Prieto-Delgado J, Diaz-Beya M, Garrido A, Benavente C, Perez-Simon JA, Moscardo F, Sanz MA, Montesinos P. A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia. ANNALS OF HEMATOLOGY. 2018; 97(5):763-772.

Autores/as: IF: 2,845 Q: 2

IF: 2,845

IF: 2,845 Q: 2

Autores/as: Serrano-Lopez J, Nattamai K, Pease NA, Shephard MS, Wellendorf AM, Sertorio M, Smith EA, Geiger H, Wells SI, Cancelas JA, Privette Vinnedge LM

Título: 2

Revista: -Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors

Serrano-Lopez J, Nattamai K, Pease NA, Shephard MS, Wellendorf AM, Sertorio M, Smith EA, Geiger H, Wells SI, Cancelas JA, Privette Vinnedge LM. 2.-Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors. EXPERIMENTAL HEMATOLOGY 2018 Mar;59:40-50

Autores/as: IF: 2

Título: 436 Q: 2

IF: 2.436

IF: 2.436 Q: 2

Autores/as: Zhang C, D'Alessandro A, Wellendorf AM, Mohmoud F, Serrano-Lopez J, Perentesis JP, Komurov K, Alexe G, Stegmaier K, Whitsett JA, Grimes HL, Cancelas JA

Título: 3

Revista: - KLF5 controls glutathione metabolism to suppress p190-BCR-ABL+ B-cell lymphoblastic leukemia

Zhang C, D'Alessandro A, Wellendorf AM, Mohmoud F, Serrano-Lopez J, Perentesis JP, Komurov K, Alexe G, Stegmaier K, Whitsett JA, Grimes HL, Cancelas JA. 3.- KLF5 controls glutathione metabolism to suppress p190-BCR-ABL+ B-cell lymphoblastic leukemia. ONCOTARGET 2018 Jul 3;9(51):29665-29679.

Autores/as: IF: 3,45 Q: 2

IF: 3,45

IF: 3,45 Q: 2

Título: Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia

Revista: LEUK LYMPHOMA

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua J, Serrano J, Gore SD, Zeidan AM. Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia. LEUK LYMPHOMA. 2019. Jan;60(1):246-249

Autores/as: IF: 2

Título: 644 Q: 2

IF: 2.644

IF: 2.644 Q: 2